16-173159-T-G

Position:

• chr16-173159-T-G

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PP3_Strong PP5_Moderate

The NM_000517.6(HBA2):​c.130T>G​(p.Phe44Val) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F44L) has been classified as Likely benign.

• Frequency: Genomes: not found (cov: 12)
• Consequence: HBA2 NM_000517.6 missense
• Clinical Significance: Pathogenic criteria provided, single submitter P:1
• Conservation: PhyloP100: 5.79

Genes affected

HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

• PP3: MetaRNN computational evidence supports a deleterious effect, 0.993
• PP5: Variant 16-173159-T-G is Pathogenic according to our data. Variant chr16-173159-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 2428504.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
HBA2	NM_000517.6	c.130T>G	p.Phe44Val	missense_variant	2/3	ENST00000251595.11	NP_000508.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
HBA2	ENST00000251595.11	c.130T>G	p.Phe44Val	missense_variant	2/3	1	NM_000517.6	ENSP00000251595	P1
HBA2	ENST00000484216.1	c.100T>G	p.Phe34Val	missense_variant	2/2	1		ENSP00000495899
HBA2	ENST00000482565.1	n.266T>G		non_coding_transcript_exon_variant	1/2	1
HBA2	ENST00000397806.1	c.34T>G	p.Phe12Val	missense_variant	2/3	2		ENSP00000380908

Frequencies

GnomAD3 genomes Cov.: 12

GnomAD4 exome Cov.: 9

GnomAD4 genome Cov.: 12

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:1

Revision: criteria provided, single submitter

Submissions by phenotype

not provided Pathogenic:1

Pathogenic, criteria provided, single submitter

clinical testing

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

Nov 15, 2022

The Hb Torino variant (HBA2; c.130T>G; p.Phe44Val, also known as Phe43Val when numbered from the mature protein, rs281864829, HbVar ID: 55) is an unstable variant reported in the heterozygous state in the literature in multiple individuals affected with hemolytic anemia (see HbVar, Beretta 1968, Prato 1970). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. Another variant at this codon (Hb Vanvitelli; p.Phe44Leu) has been reported in the compound heterozygous state in an individual with hemolytic anemia and is considered pathogenic (Casale 2019). The phenylalanine at codon 44 is highly conserved and computational analyses predict that this variant is deleterious (REVEL:0.95). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Beretta A et al. Haemoglobin Torino--alpha-43 (CD1) phenylalanine replaced by valine. Nature. 1968 Mar 16;217(5133):1016-8. PMID: 5643522. Casale M et al. Hb Vanvitelli: A new unstable a-globin chain variant causes undiagnosed chronic haemolytic anaemia when co-inherited with deletion?-?a3.7. Clin Biochem. 2019 Dec;74:80-85. PMID: 31493379. Prato V et al. Haemolytic anaemia due to haemoglobin Torino. Br J Haematol. 1970 Jul;19(1):105-15. PMID: 5453914. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.53	D
BayesDel_noAF	Pathogenic	0.52
CADD	Uncertain	25
DANN	Uncertain	0.99
DEOGEN2	Benign	0.27	.;T
Eigen	Pathogenic	0.78
Eigen_PC	Uncertain	0.63
FATHMM_MKL	Uncertain	0.97	D
M_CAP	Pathogenic	0.95	D
MetaRNN	Pathogenic	0.99	D;D
MetaSVM	Pathogenic	0.93	D
MutationTaster	Benign	1.0	D;D
PrimateAI	Uncertain	0.72	T
PROVEAN	Pathogenic	-6.8	D;D
REVEL	Pathogenic	0.95
Sift	Pathogenic	0.0	D;D
Sift4G	Pathogenic	0.0	D;D
Vest4		0.86
MutPred		0.95		Gain of phosphorylation at Y43 (P = 0.1277);.;
MVP		1.0
MPC		2.8
ClinPred		1.0	D
GERP RS		4.2
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.7
gMVP		0.99

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs281864829; hg19: chr16-223158;